Root Financial Partners
BBIO icon

Root Financial Partners’s BridgeBio Pharma BBIO Stock Holding History

Root Financial Partners’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27.8K Buy
+423
New +$32.9K ﹤0.01% 1377
2026
Q2 		– Sell
-343
Closed -$25.5K – 692
2026
Q1 		$25.5K Buy
343
+66
+24% +$4.78K ﹤0.01% 1192
2025
Q4 		$21.2K Buy
277
+12
+5% +$788 ﹤0.01% 1157
2025
Q3 		$13.8K Buy
+265
New +$12.9K ﹤0.01% 1299

Other funds holding BBIO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Kohlberg Kravis Roberts & Co
Kohlberg Kravis Roberts & Co New York $5.04B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aisling Capital Management
Aisling Capital Management New York $299M AUM 39.78% 1-Year Est. Return

Root Financial Partners's BBIO Position: Q3 2026 in Review

Root Financial Partners opened a new position in BridgeBio Pharma (BBIO) in Q3 2026: 423 shares worth $27.8K. The stake represents ﹤0.01% of the portfolio and ranks #1377 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in BBIO as recently as Q1 2026.

Root Financial Partners first reported a position in BBIO in Q3 2025 and has held it in 4 quarters since. 348 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • Root Financial Partners held 423 shares of BridgeBio Pharma worth $27.8K as of Q3 2026.
  • BridgeBio Pharma was a new Root Financial Partners position in Q3 2026.
  • BridgeBio Pharma made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #1377 holding.
  • Root Financial Partners first reported a position in BridgeBio Pharma in Q3 2025 and has held it in 4 quarters since.
  • 348 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.